I

Inventurus Knowledge Solutions Ltd
NSE:IKS

Watchlist Manager
Inventurus Knowledge Solutions Ltd
NSE:IKS
Watchlist
Price: 1 559.9 INR 2.5% Market Closed
Market Cap: ₹261.3B

P/S

8.7
Current
0%
More Expensive
vs 3-y average of 8.7

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
8.7
=
Market Cap
₹243.2B
/
Revenue
₹30.6B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
8.7
=
Market Cap
₹243.2B
/
Revenue
₹30.6B

Valuation Scenarios

Inventurus Knowledge Solutions Ltd is trading above its 3-year average

If P/S returns to its 3-Year Average (8.7), the stock would be worth ₹1 559 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-70%
Maximum Upside
No Upside Scenarios
Average Downside
24%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 8.7 ₹1 559.9
0%
3-Year Average 8.7 ₹1 559
0%
5-Year Average 8.7 ₹1 559
0%
Industry Average 6.6 ₹1 185.7
-24%
Country Average 2.6 ₹466.59
-70%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
₹243.2B
/
Jan 2026
₹30.6B
=
8.7
Current
₹243.2B
/
Mar 2026
₹32.3B
=
7.5
Forward
₹243.2B
/
Mar 2027
₹38.7B
=
6.3
Forward
₹243.2B
/
Mar 2028
₹45.5B
=
5.3
Forward
₹243.2B
/
Mar 2029
₹52B
=
4.7
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Average P/E: 64.8
40.3
N/A N/A
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
28.5
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
60.1
29%
2.1
JP
M3 Inc
TSE:2413
20.8
16%
1.3
SE
Sectra AB
STO:SECT B
91.8
14%
6.6
US
W
Waystar Holding Corp
NASDAQ:WAY
42.2
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.7
15%
1.2
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -61.4
69%
N/A

Market Distribution

Higher than 86% of companies in India
Percentile
86th
Based on 2 983 companies
86th percentile
8.7
Low
0 — 1.5
Typical Range
1.5 — 4.6
High
4.6 —
Distribution Statistics
India
Min 0
30th Percentile 1.5
Median 2.6
70th Percentile 4.6
Max 56 363.4

Inventurus Knowledge Solutions Ltd
Glance View

Market Cap
261.3B INR
Industry
Health Care

Inventurus Knowledge Solutions Ltd is a IN-based company operating in Health Care Technology industry. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 12,405 full-time employees. The company went IPO on 2024-12-19. Inventurus Knowledge Solutions Limited is an India-based company. The firm is a technology-enabled healthcare solutions provider and offers a care enablement platform assisting physician enterprises in the United States, Canada and Australia, with a focus on the United States market. The company offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Its technology solutions include IKS EVE, Optimix, IKS Stacks, IKS AssuRx, Dashboard, and IKS Scribble. IKS EVE is its multichannel patient access and patient engagement solution. Optimix is its proprietary workflow management platform for revenue optimization. IKS Stacks scans, identifies and abstracts relevant data from incoming clinical documents. In addition, it also uses robotic process automation (RPA) to help automate structured and repetitive processes in virtual desktop/ application environments. Its other platforms include QTranscribe/Medico-Legal, QDocprep, QScribe Assist, and QCode.

IKS Intrinsic Value
1 126.92 INR
Overvaluation 28%
Intrinsic Value
Price ₹1 559.9
I
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett